EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1

Haodi Dong, Runhong Zhou, Jing Chen, Jing Wei, Zimeng Wei, Ziqing Yang, Kun Zhu, Yufan Yang, Qianqian Yang, Na Liu, Yuting Chen, Yuhan Wu und 13 weitere

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Haodi Dong und 24 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua Medicin…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Single-Domain Antibodies, Antibodies, Neutralizing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Plan for Scientific Research and Development of China, National Natural Science Foundation, Wanke Scientific Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ongoing evolution and immune escape of SARS-CoV-2, alongside the potential threat of SARS-CoV-1 and other sarbecoviruses, underscore the urgent need for effective strategies against their infection and transmission. This study highlights the discovery of nanobodies from immunized alpacas, which demonstrate exceptionally broad and potent neutralizing capabilities against the recently emerged and more divergent SARS-CoV-2 Omicron subvariants including JD.1.1, JN.1, KP.3, KP.3.1.1, as well as SARS-CoV-1 and coronaviruses from bats and pangolins utilizing receptor ACE2. Among these, Tnb04-1 emerges as the most broad and potent, binding to a conserved hydrophobic pocket in the spike’s receptor-binding domain, distinct from the ACE2 binding site. This interaction disrupts the formation of a proteinase K-resistant core, crucial for viral-cell fusion. Notably, intranasal administration of Tnb04-1 in Syrian hamsters effectively prevented respiratory infection and transmission of the authentic Omicron XBB.1.5 subvariant. Thus, Thb04-1 holds promise in combating respiratory acquisition and transmission of diverse sarbecoviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Single-Domain AntibodiesAntibodies, NeutralizingAntibodies, ViralCamelids, New WorldAnimalsHumansSpike Glycoprotein, CoronavirusSevere acute respiratory syndrome-related coronavirusCricetinaeMesocricetusChiroptera

Substanzen

Single-Domain AntibodiesAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing, China.
  • AIDS Institute, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People's Republic of China.
  • The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biot…
  • School of Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States.

ORCID-Profile: Linqi Zhang

Förderung

  • National Key Plan for Scientific Research and Development of China
  • National Natural Science Foundation
  • Wanke Scientific Research Program
  • Hong Kong Research Grants Council Collaborative Research Fund
  • The Health@InnoHK, Innovation and Technology Commission of Hong Kong
  • The Emergency Key Program of Guangzhou Laboratory
  • The Hong Kong Research Grants Council Theme-Based Research Scheme
  • The Hong Kong Health and Medical Research Fund

Zitieren

APA

Dong, H., Zhou, R., Chen, J., Wei, J., Wei, Z., Yang, Z., Zhu, K., Yang, Y., Yang, Q., Liu, N., Chen, Y., Wu, Y., Liang, Y., Zeng, Y., Guo, Q., Li, M., Shan, S., Wang, H., Niu, M., …, & Zhang, L. (2024). Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012625

Vancouver

Dong H, Zhou R, Chen J, Wei J, Wei Z, Yang Z, et al. Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012625

BibTeX
@article{Dong2024,
  author = {Dong, Haodi and Zhou, Runhong and Chen, Jing and Wei, Jing and Wei, Zimeng and Yang, Ziqing and Zhu, Kun and Yang, Yufan and Yang, Qianqian and Liu, Na and Chen, Yuting and Wu, Yuhan and Liang, Yan and Zeng, Yige and Guo, Qile and Li, Mingxi and Shan, Sisi and Wang, Han and Niu, Mengyue and Yunfei Zeng, Isabella and Shi, Xuanling and Zhang, Qi and Wang, Xinquan and Chen, Zhiwei and Zhang, Linqi},
  title = {Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012625}
}
Kostenlos starten →